Eli Lilly and Co at Goldman Sachs Healthcare Conference Transcript
All right, let's get right into our next session. Very, very excited to have Eli Lilly here with us, Ken Custer, EVP. We were joking before, someone who dominated ADA, he looks well. Mike Czapar, thank you again for being with us.
Questions & Answers
Ken, let's just get straight to the discussion just to tee you up high level, and we're going to talk about a lot of your programs and your products. But I want to start at sort of 10,000 feet, so much happening in obesity, very dynamic field that Lilly is really trailblazing and at the leading edge of where this market is headed. Talk to us about what's been most surprising to you in terms of how this market is developing and what the landscape might look like in, call it, five years.
First, great to be here and great to see everyone. We're in a very privileged position right now to have been a part of the earliest innings of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
